A Stanford-led study finds Resero Bio’s uRARE-seq urine cfRNA test detects bladder cancer and predicts therapy response in 683 samples.

Astrin Biosciences' Certitude blood test for supplemental breast cancer screening is now available to eligible women across ...

A bipartisan Senate bill would require Medicare contractors to review local coverage requests within 60 days and increase ...

Leica Biosystems has acquired StatLab Medical Products, expanding its anatomic pathology portfolio with consumables and ...

Lund University receives $19.4M NIH grant to clinically validate MTBR-tau243 blood test for Alzheimer’s staging and prognosis ...

Roche’s TIB MOLBIOL launches a newborn screening kit for SMA, SCID, and sickle cell disease, designed for use on LightCycler ...

A phase III trial ancillary analysis found the Decipher Prostate Test predicts which intermediate-risk prostate cancer ...

Early data from a new pathology institute in Germany highlight referral patterns, case mix stability, and workload insights ...

Revvity has launched the GSP T1D 3plex kit, a fully automated, CE-IVDR-certified, multiplex autoantibody detection solution ...

Lucid Diagnostics receives CMS panel support to maintain EsoGuard Medicare payment, gains new CPT code for EsoCheck, and ...

An FDA panel voted in favor of GRAIL’s Galleri multi-cancer early detection test, citing benefits outweigh risks for adults ...

Thermo Fisher Scientific introduces the Nicolet RaptIR X FTIR Microscope, offering optical and infrared analysis for ...